Welcome to Credo's Ingredient Library.
It’s an in-depth look inside the science behind the Credo Standard™: what ingredients do, how they can affect our health and the world around us, and why we welcome some, restrict others, and leave a few off our shelves.
Have something in mind? Browse by name. Just looking? Start anywhere. There’s plenty to learn, and you don’t need a chemistry degree to enjoy it.
Ingredient or Ingredient Class
A-F
-
Aluminum Powder
What is Aluminum Powder and why is it used in cosmetic and personal care products?Aluminum Powder (also known as CI 77000) is elemental aluminum in a fine powder form. In cosmetics, aluminum powder is used as a metallic pigment to add a silver/grey lustre. It is not an active ingredient and it is not the aluminium found in antiperspirants, which is a different class of compounds (aluminum salts).
What does science say?In 1977 the U.S. FDA approved CI 77000 as a colorant, with the approval requiring purity specifications along with prescribed conditions of use (1,2). Specifically, CI 77000 is approved for use in externally applied cosmetics, including products for the eye area but not lip products, subject to purity specifications. This approval was not published along with any public safety assessment and aluminum powder (CI 77000) has never been individually assessed by the US Cosmetic Ingredient Review Expert Panel.
Why does Credo prohibit Aluminium Powder?
The EU's Scientific Committee on Consumer Safety has published a series of five documents on aluminium in cosmetics between 2014 and 2024 (3–7), but these assess aluminium-containing ingredients as a class, on an elemental aluminium basis; i.e., it is not specific to aluminium powder but describe aluminium generally. In 2014 SCCS noted that aluminium is a "known systemic toxicant at high doses", meaning at high enough doses there can be adverse effects on the body. This conclusion was grounded in historical toxicology studiesa with ingested aluminium. However, SCCS was not able to conclude at that time if exposure to aluminium from cosmetics actually posed a human health risk because there was no available data on how much aluminium passes through skin and if this amount was greater than or less than the amount known to cause toxicity (3).
In 2020 data became available that demonstrated a minimal amount of aluminium can get through the skin, approximately just 0.0005% of the applied amount of aluminum can enter the body (4). On that basis, the SCCS concluded that aluminium-containing ingredients are safe when used at or below maximum levels SCCS specified for given product categories (7).
SCCS also noted that diet is a major source of aluminium exposure, contributing on a similar order of magnitude to cosmetics under its conservative estimates, and that when cosmetic, dietary and pharmaceutical sources are combined, the most highly exposed consumers may exceed established safe intake limits (6,7). Neither SCCS nor CIR have evaluated inhalation exposure to aluminium powder from loose powder formulations; the assessments above address dermal and oral route.Based on a review of the available data Credo has opted to take the precautionary approach and prohibit aluminium powder from any products sold by Credo to minimize the potential for any adverse human health affects. These ingredients also reach people through sources beyond cosmetics and each of those uses is reviewed for safety on its own rather than added together. Where credible evidence points to the potential for long-term health concerns (even amid uncertainty) and viable alternatives exist, Credo applies a precautionary approach rather than waiting for the science to settle.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- 21 CFR 73.1645 - Aluminum powder (identity, specifications, drugs) [Internet]. Sect. 73.1645. U.S. Food and Drug Administration; 1977 Jul 29. Available from: https://www.law.cornell.edu/cfr/text/21/73.1645
- 21 CFR 73.2645 - Aluminum powder (cosmetics) [Internet]. Sect. 73.2645. U.S. Food and Drug Administration; 1977 Jul 29. Available from: https://www.law.cornell.edu/cfr/text/21/73.2645
- Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of aluminium in cosmetic products [Internet]. Brussels, Belgium: European Commission, Directorate-General for Health and Food Safety; 2014 Jun [cited 2026 Aug 5]. Available from: https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_153.pdf
- Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of aluminium in cosmetic products - Submission II [Internet]. Brussels, Belgium: European Commission, Directorate-General for Health and Food Safety; 2020 Mar [cited 2026 Aug 5]. Available from: https://health.ec.europa.eu/publications/safety-aluminium-cosmetic-products-submission-ii_en
- Scientific Committee on Consumer Safety (SCCS). Addendum to the scientific opinion SCCS/1613/19 on the safety of aluminium in cosmetic products (lipstick) - Submission II [Internet]. Brussels, Belgium: European Commission, Directorate-General for Health and Food Safety; 2021 Mar [cited 2026 Aug 5]. Available from: https://health.ec.europa.eu/document/download/4b5b8695-c7dc-47ac-928d-58d537d88707_en?filename=sccs_o_248.pdf
- Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of aluminium in cosmetic products - Submission III [Internet]. Brussels, Belgium: European Commission, Directorate-General for Health and Food Safety; 2023 Feb [cited 2026 Aug 5]. Available from: https://health.ec.europa.eu/publications/sccs-safety-aluminium-cosmetic-products-submission-iii_en
- Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of aluminium in cosmetic products - Submission IV [Internet]. Brussels, Belgium: European Commission, Directorate-General for Health and Food Safety; 2024 Mar [cited 2026 Aug 5]. Available from: https://health.ec.europa.eu/publications/safety-aluminium-cosmetic-products-submission-iv_en
-
Animal Derived
What are animal-derived ingredients and why are they used in cosmetic and personal care products?Animal-derived ingredients are ingredients obtained from animals or animal byproducts. They are used in cosmetics for a variety of purposes, including moisturizing, conditioning, emulsifying, and improving product texture. Many of these functions can also be achieved using plant-derived, mineral-derived, fermentation-derived, or synthetic alternatives.
What does science say?Animal-derived ingredients are not inherently safer or less safe than ingredients from other sources. Their safety depends on the specific ingredient, how it is manufactured, and how it is used in a formulation. In many cases, the same ingredient can be sourced from animals, plants, or synthetic processes while providing the same function and performance.
Why does Credo restrict animal-derived ingredients?Credo's restrictions are based primarily on ingredient sourcing (i.e., the use of animals); not on any human health concern. When a comparable non-animal alternative is available, Credo requires ingredients to be sourced from plants, minerals, fermentation, or synthetic processes instead.
Animal-derived ingredients vs. animal testing
Recognizing that suitable alternatives are not yet available for every application, Credo permits a very limited number of animal-derived ingredients. These are: beeswaxa, lanolin, keratin, shellac, cholesterol, lactose, and carmine. Brands are encouraged to obtain assurances that these ingredients are sourced with consideration for animal welfare.Animal-derived ingredients and animal testing are separate issues. An ingredient may be animal-derived without the finished product or its ingredients being tested on animals.
Credo's approach
Credo does not permit any products that are tested on animals.Credo's goal is to encourage thoughtful ingredient sourcing. Rather than prohibit every animal-derived ingredient outright, our standard prioritizes non-animal alternatives where they offer comparable performance, while recognizing that certain applications may still require animal-derived materials and we aim to support functional alternatives to these as much as feasibility possible. Note, Credo’s online product listings will show a “vegan” label if you’re looking to ensure a product doesn’t use any animal derived ingredients.
a Note: Royal jelly is prohibited
-
Butylated Ingredients (e.g. BHA, BHT)
What are butylated ingredients and why are they used in cosmetic and personal care products?Butylated ingredients are a class of ingredients that have been chemically modified to improve their stability or performance. In cosmetics, some butylated ingredients are used as antioxidants to help prevent oils and other ingredients from breaking down over time, while others help stabilize formulations or improve product performance (1). Common examples include butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
What does science say?In the US, the Cosmetic Ingredient Review (CIR) Expert Panel has reviewed both BHA and BHT repeatedly since the 1980s and concluded that both are safe in cosmetics as currently used. CIR doesn’t set a maximum limit, it reviews the concentrations industry reports using, most recently up to 0.5% for BHT and 0.15% for BHA (2,3). In the EU, BHT has been restricted in law since 2023 to 0.001% in mouthwash, 0.1% in toothpaste and 0.8% in other products (4). These restrictions are concentrations at which adverse liver and reproductive and developmental effects are not anticipated to occur.
Why does Credo prohibit butylated ingredients?
BHA has never been regulated in the EU. In March 2026 the Scientific Committee on Consumer Safety (SCCS) recommended limiting the amount allowed in cosmetics to 0.07%. Below this proposed maximum concentration adverse liver effects are not anticipated to occur. Notably oral care and products that could be inhaled, such as sprays and loose powders, were not included in this evaluation (1). BHA is also classified as “possibly carcinogenic to humans” (Group 2B) by the International Agency for Research on Cancer and as “reasonably anticipated to be a human carcinogen” by the US National Toxicology Program (5,6). These are hazard classifications: they ask whether a substance could cause harm under some conditions, rather than whether it does at the amounts people are actually exposed to. These classifications are primarily based on a type of tumor observed in rodents fed high doses of BHA over long periodsa which have been deemed of minimal relevance to humans (7,8), though this conclusion has not been withdrawn by either agency. Reviewing the same evidence, both the SCCS and the CIR Expert Panel concluded that carcinogenicity is not a concern at the concentrations used in cosmetics (1,3).
Whether these ingredients affect hormones is a question that remains open. For BHT, the SCCS found that neither computational modeling nor cell studies indicated endocrine-disrupting properties (9). However, there is evidence at high enough exposure it can cause adverse reproductive and development effects (9). For BHA, cell studies have shown estrogen-like and anti-androgen-like activity, but the available animal studies on hormonal effects were judged methodologically weak. The CIR Expert Panel similarly noted that effects appeared mainly in cell systems and at concentrations far above anything reached through cosmetic use (1,3). Independent researchers have also explored this question, landing on both sides of the debate (10–13).Because some butylated ingredients have shown endocrine activity in laboratory studies, along with adverse reproductive and liver effects, and because scientific questions about this class remain open, we choose to prohibit butylated ingredients in products sold at Credo. This is done out of precaution and in line with customer preference. These ingredients also reach people through sources beyond cosmetics, including food and food packaging, and each of those uses is reviewed on its own rather than added together. Scientific and regulatory bodies have reached differing conclusions about the concentrations and product types for which these ingredients are appropriate. Where credible evidence points to the potential for long-term health concerns (even amid uncertainty) and viable alternatives exist, Credo applies a precautionary approach rather than waiting for the science to settle.
Credo's approachProduct stability is essential to both product safety and performance. Credo encourages brands to formulate with antioxidant and stabilization systems that maintain product quality while avoiding butylated ingredients.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- Scientific Committee on Consumer Safety. Scientific Advice on Butylate Hydroxyanisole [Internet]. 2026 [cited 2026 Aug 5]. Report SCCS/1682/85. Available from: https://health.ec.europa.eu/document/download/502956f3-471d-4e2d-899f-08aa4511bb90_en?filename=sccs_o_306.pdf
- Burnett C, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG, et al. BHT – Butylated Hydroxytoluene. Int J Toxicol. 2023 Dec;42(3_suppl):17S-19S. doi:10.1177/10915818231204256
- Cosmetic Ingredient Review. Amended Safety Assessment of BHA as Used in Cosmetics. 2025 Jan. Available from: https://cir-reports.cir-safety.org/view-attachment/?id=28daedc3-995d-77c6-b63e-4698dccde09d
- European Parliament and Council of the European Union. COMMISSION REGULATION (EU) 2022/2195 of 10 November 2022 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Butylated Hydroxytoluene, Acid Yellow 3, Homosalate and HAA299 in cosmetic products and correcting that Regulation as regards the use of Resorcinol in cosmetic products [Internet]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?from=EN&uri=CELEX%3A32022R2195
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42 [Internet]. Lyon, France: International Agency for Research on Cancer; 1987 [cited 2026 Aug 6]. 440 p. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7). Available from: https://publications.iarc.who.int/139
- National Toxicology Program (NTP). Butylated Hydroxyanisole. In: 15th Report on Carcinogens [Internet]. Research Triangle Park, NC: National Toxicology Program, U.S. Department of Health and Human Services; 2021 [cited 2026 Aug 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK590883/ doi:10.22427/NTP-OTHER-1003
- Williams GM, Iatropoulos MJ. Butylated hydroxyanisole. In: Baan RA, Partensky C, editors. Predictive Value of Rodent Forestomach and Gastric Neuroendocrine Tumours in Evaluating Carcinogenic Risks to Humans: Views and Expert Opinions of an IARC Working Group, Lyon, 29 November-1 December 1999 [Internet]. Lyon, France: IARC Press; 2003 [cited 2026 Aug 11]. p. 31–40. (IARC Technical Publication No. 39). Available from: https://monographs.iarc.who.int/wp-content/uploads/2022/09/IARC_2003.Tech-Pub_No.39Summary_Reports.pdf
- International Agency for Research on Cancer (IARC). Predictive Value of Rodent Forestomach and Gastric Neuroendocrine Tumours in Evaluating Carcinogenic Risks to Humans: Views and Expert Opinions of an IARC Working Group, Lyon, 29 November-1 December 1999 [Internet]. Lyon, France: IARC Press; 2003 [cited 2026 Aug 11]. (Baan RA, Partensky C, editors. IARC Technical Publication No. 39). Available from: https://monographs.iarc.who.int/wp-content/uploads/2022/09/IARC_2003.Tech-Pub_No.39Summary_Reports.pdf
- Scientific Committee on Consumer Safety (SCCS). Opinion on Butylated Hydroxytoluene (BHT) [Internet]. Luxembourg: European Commission, Directorate-General for Health and Food Safety; 2021 Dec [cited 2026 Aug 6]. Available from: https://health.ec.europa.eu/publications/butylated-hydroxytoluene-bht_en
- A. Pop, B. Kiss, F. Loghin. Endocrine disrupting effects of butylated hydroxyanisole (BHA - E320). Clujul Med [Internet]. 2013. Available from: https://www.semanticscholar.org/paper/602ff966e7273f93bc10a700a10a1a6b8e0c0661
- A. Pop, T. Drugan, A. Gutleb, D. Lupu, Julien Cherfan, F. Loghin, et al. Estrogenic and anti–estrogenic activity of butylparaben, butylated hydroxyanisole, butylated hydroxytoluene and propyl gallate and their binary mixtures on two estrogen responsive cell lines (T47D–Kbluc, MCF-7). J Appl Toxicol. 2018. doi:10.1002/jat.3601
- K. De Abrew, Ted E. Natoli, C. Lester, Xiaohong Wang, Mahmoud Shobair, A. Subramanian, et al. A New Approach Methodology (NAM) Based Assessment of Butylated hydroxytoluene (BHT) for Endocrine Disruption Potential. Toxicol Sci. 2022. doi:10.1093/toxsci/kfac099
- Xiaoxi Yang, Wenting Song, Na Liu, Zhendong Sun, Ruirui Liu, Qian S. Liu, et al. Synthetic Phenolic Antioxidants Cause Perturbation in Steroidogenesis in Vitro and in Vivo. Environ Sci Technol. 2018. doi:10.1021/acs.est.7b05057
-
Cyclic Silicones
What are cyclic silicones and why are they used in cosmetic and personal care products?Silicones are group of synthetic ingredients built around the elements silicon and oxygen. They are widely used in cosmetics to improve texture, condition skin and hair, prevent caking, and help dissolve or distribute other ingredients.
Credo does not prohibit all silicones. Linear silicones, such as Dimethicone, can create a smooth texture, temporarily soften the appearance of fine lines, and condition hair. These large, stable molecules are not expected to pose a health risk when used in cosmetics.
However, silicones can persist in the environment. Some people with acne-prone or sensitive skin may also prefer to avoid silicone-containing products if they find certain formulas too occlusive, although silicones are not inherently comedogenic.
Credo prohibits the following cyclic silicones, which have a ring-shaped molecular structure:- Cyclotetrasiloxane (D4)
- Cyclopentasiloxane (D5)
- Cyclohexasiloxane (D6)
- Cyclomethicone
“Cyclomethicone” is not one specific ingredient. It is a mixture that can contain several cyclic silicones.
What does science say?
The following is referring to cyclic silicones.The Cosmetic Ingredient Review (CIR) panel has evaluated cyclic silicones for several decades, most recently in 2011 (1–3). The CIR, which evaluates human health rather than environmental effects, concluded that these ingredients were safe under the cosmetic uses and concentrations assessed.
Why does Credo prohibit cyclic silicones?
At the time of the review, the maximum reported concentrations were 89% for Cyclomethicone, 28% for D4, 93% for D5, and 48% for D6. These figures describe how the ingredients were being used in 2008; they are not regulatory limits. The CIR’s conclusion was based on the available toxicological evidence and studies showing that very little of these compounds passes through the skin. The panel also concluded that hairsprays did not pose an inhalation risk because the droplets produced were generally too large to travel deeply into the lungs (1).
In the European Union these compounds have been reviewed both for human health and environmental effects. With respect to human health, the EU Scientific Committee on Consumer Safety has reviewed the data for D4 and D5 and similarly concluded that at the exposure amounts expected from cosmetic products, consumers are not a risk (4,5). One notable exception was D5 in hair-styling aerosols and sun-care sprays. The committee concluded that these products could produce airborne concentrations above the level it considered safe.
Separately, the EU classified D4 as a substance suspected of harming reproduction (6). This is a hazard classification: it identifies what a substance may be capable of causing under certain conditions, rather than the risk posed by a particular level of exposure. EU cosmetics law generally prohibits substances classified as carcinogenic, mutagenic, or toxic to reproduction, subject to limited exceptions.
The broader concern with D4, D5, and D6 is their environmental impact. This, not a demonstrated health risk from typical cosmetic use, is the primary reason all three have been restricted in the EU (7). The EU concluded that these compounds have properties of very persistent and very bioaccumulative substances. In other words, they can remain in the environment for a long time and accumulate in living organisms and food chains. D4 was also determined to be toxic to the environment. EU restrictions limit D4, D5, and D6 to trace concentrations in specified cosmetic products, effectively preventing their intentional use as those restrictions take effect.Credo prohibits D4, D5, D6, and Cyclomethicone primarily because of their environmental persistence and potential to accumulate in ecosystems.
Credo's approach
We also take a precautionary approach when credible evidence indicates a potential long-term health concern and effective alternatives are available. For example, although cosmetic safety assessments generally conclude that exposure to D4 from an individual product is too low to pose a risk, these assessments may not fully capture a person’s combined exposure across multiple products and other sources.
Given the environmental concerns, the reproductive-hazard classification of D4, and the availability of alternatives, Credo does not allow cyclic silicones.
Credo continues to permit linear silicones because they do not present the same level of concern and, for some cosmetic functions, suitable alternatives are not yet widely available.Credo's ingredient restrictions are informed by the Credo Methodology™.
References
- Johnson Jr W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Safety Assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane, and Cycloheptasiloxane. Int J Toxicol. 2011 Dec 1;30(6_suppl):149S-227S. doi:10.1177/1091581811428184
- Cosmetic Ingredient Review Expert Panel. Final Report on the Safety Assessment of Cyclomethicone. J Am Coll Toxicol. 1991;10(1):9–19. doi:10.3109/10915819109078619
- Cosmetic Ingredient Review Expert Panel. Amended Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane, and Cycloheptasiloxane [Amended final report]. Washington, DC: Cosmetic Ingredient Review; 2009 Dec.
- Scientific Committee on Consumer Safety (SCCS). Opinion on Cyclomethicone – Octamethylcyclotetrasiloxane (Cyclotetrasiloxane, D4) and Decamethylcyclopentasiloxane (Cyclopentasiloxane, D5) [Scientific opinion] [Internet]. Brussels: European Commission, Directorate-General for Health and Consumers; 2010 Jun. Scientific opinion SCCS/1241/10. Available from: https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_029.pdf
- Scientific Committee on Consumer Safety (SCCS). Opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products [Scientific opinion] [Internet]. Luxembourg: European Commission, Directorate-General for Health and Food Safety; 2015 Mar. Scientific opinion SCCS/1549/15. Available from: https://health.ec.europa.eu/system/files/2021-08/sccs_o_174_0.pdf
- European Parliament and Council of the European Union. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance) - consolidated text of 1 July 2026. Official Journal of the European Union [Internet]. Brussels: European Parliament and Council of the European Union; 2026 Jul 1. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02008R1272-20260701
- European Parliament and Council of the European Union. Commission Regulation (EU) 2018/35 of 10 January 2018 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards octamethylcyclotetrasiloxane (‘D4’) and decamethylcyclopentasiloxane (‘D5’). Official Journal of the European Union. European Commission; 2018 Jan 10. p. 45.
-
Ethoxylated Ingredients (e.g., PEGs, Polysorbates)
What are ethoxylated ingredients and why are they used in cosmetic and personal care products?Ethoxylated ingredients are a broad class of ingredients produced by reacting a starting material with ethylene oxide, a common manufacturing process known as ethoxylation (1). This process can improve an ingredient's performance by making it more water-soluble, helping oil and water mix, enhancing cleansing, or improving how a product spreads across the skin or hair.
What does science say?
Thousands of cosmetic ingredients are produced using ethoxylation. Common examples include polyethylene glycols (PEGs), polysorbates, sodium laureth sulfate (SLES), ceteareths, and ingredients with names ending in “-eth” (1–3). These ingredients can function as surfactants, emulsifiers, solubilizers, thickeners, and conditioning agents in products ranging from shampoos and cleansers to lotions and creams.The primary scientific discussion surrounding ethoxylated ingredients is generally not about the finished ingredients themselves, but rather about how they are manufactured.
Why does Credo prohibit or restrict ethoxylated ingredients?
Ethoxylation uses ethylene oxide, a highly reactive chemical classified as a human carcinogen (4,5). During manufacturing, trace amounts of ethylene oxide may remain in the finished ingredient, and a byproduct called 1,4-dioxane can also be formed (1,3,6). 1,4 dioxane is also classified as a possible human carcinogen (7). Both compounds are considered contaminants rather than intentional ingredients and are not added to cosmetic formulations (8).
Modern manufacturing and purification processes can substantially reduce residual ethylene oxide and 1,4-dioxane (1). Manufacturers and regulators may also test ingredients and finished products to verify that contaminant levels remain very low (9). Regulatory agencies generally do not prohibit ethoxylated ingredients in cosmetics, but they do expect manufacturers to use good manufacturing practices to minimize contaminants whenever technically feasible (9).
Although exposure to residual contaminants from cosmetics is expected to be low, the presence of carcinogenic manufacturing feedstocks and the potential for trace contamination continue to be an area of interest for scientists, regulators, and retailers seeking to reduce avoidable sources of exposure.Ethoxylated ingredients are not all treated the same under The Credo Standard™ as it’s a chemical class of thousands of ingredients with different structures and functions. As a result, Credo evaluates these ingredients as a class based on both their manufacturing process and the availability of safer alternatives, rather than assuming every ethoxylated ingredient presents the same level of concern.
For many common ingredient classes, including sodium laureth sulfate (SLES), ammonium laureth sulfate, PEGs, polysorbates, ceteareths, emulsifying waxes containing ethoxylated ingredients, and other ingredients ending in “-eth,” Credo prohibits their use because suitable non-ethoxylated alternatives are widely available.
For other ethoxylated or alkoxylated ingredients, however, effective alternatives may not yet exist for every cosmetic application. Rather than prohibit these ingredients outright, Credo allows their use only under specific conditions designed to minimize potential contaminant exposure.
Manufacturers must demonstrate that:- no suitable non-ethoxylated alternative is currently available for the intended function;
- residual ethylene oxide is below 1 ppm;
- 1,4-dioxane contamination in the ingredient is below 10 ppm; and
- finished products containing more than 10% ethoxylated ingredients have analytical testing demonstrating less than 1 ppm 1,4-dioxane.
This approach reflects Credo's broader ingredient philosophy: encouraging the use of alternative chemistries where feasible while applying additional safeguards in situations where ethoxylated ingredients remain necessary.
Credo's approachWhere feasible alternatives exist, Credo favors manufacturing processes that avoid carcinogenic feedstocks. Where alternatives are not yet available, we require additional supplier documentation and analytical testing to help verify that contaminant levels remain as low as reasonably achievable.
References
- Cosmetic Ingredient Review. Final Report of the Cosmetic Ingredient Review Expert Panel: Amended Safety Assessment of Triethylene Glycol and Polyethylene Glycol [Internet]. 2010 Jun [cited 2026 Aug 6]. Available from: https://cir-reports.cir-safety.org/view-attachment/?id=359cc595-8c74-ec11-8943-0022482f06a6
- Robinson VC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Marks JG, et al. Final Report of the Amended Safety Assessment of Sodium Laureth Sulfate and Related Salts of Sulfated Ethoxylated Alcohols. Int J Toxicol. 2010 May;29(4_suppl). doi:10.1177/1091581810373151
- Cosmetic Ingredient Review. Safety Assessment of Polysorbates as Used in Cosmetics. 2015. Available from: https://cir-reports.cir-safety.org/view-attachment/?id=657faea7-8c74-ec11-8943-0022482f06a6
- IARC Working Group on the Identification of Carcinogenic Hazards to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans [Internet]. Lyon, France: World Health Organization; 2008. Report no.: 97. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/1-3-Butadiene-Ethylene-Oxide-And-Vinyl-Halides-Vinyl-Fluoride-Vinyl-Chloride-And-Vinyl-Bromide--2008
- US EPA. IRIS: Ethylene Oxide [Reports and Assessments] [Internet]. 2016 [cited 2026 Aug 6]. Ethylene oxide. Available from: https://iris.epa.gov/ChemicalLanding/&substance_nmbr%3D1025
- Urbano Salvador A. Analysis of Cosmetic Products [Internet]. Oxford: Elsevier Science & Technology; 2011. Available from: https://www.sciencedirect.com/book/edited-volume/9780444522603/analysis-of-cosmetic-products
- IARC Working Group on the Identification of Carcinogenic Hazards to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Vol 71 Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Lyon, France. Report Volume 71. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Re-evaluation-Of-Some-Organic-Chemicals-Hydrazine-And-Hydrogen-Peroxide-Part-1-Part-2-Part-3--1999
- International Cooperation on Cosmetics Regulation. Report of the ICCR Working Group: Considerations on Acceptable Trace Level of 1,4-Dioxane in Cosmetic Products. Report Traces/1,4-Dioxane Report/Final-January 2017. Available from: https://www.iccr-cosmetics.org/topics-documents/12:traces
- U.S. FDA. 1,4-Dioxane in Cosmetics: A Manufacturing Byproduct [Internet]. FDA; March 3, 2022 [cited 2026 Aug 6]. 1,4-Dioxane in Cosmetics: A Manufacturing Byproduct. Available from: https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct
Ingredient or Ingredient Class
G-K
-
Hydroquinones
What is hydroquinone and why is it used in cosmetic and personal care products?Hydroquinone is an ingredient used to lighten areas of darkened skin by reducing the production of melanin, the pigment that gives skin its color. It has historically been used to address hyperpigmentation, including dark spots and uneven skin tone.
What does the science say?
Hydroquinone monomethyl ether (also called p-hydroxyanisole or mequinol) has also been used as a skin-lightening agent. Hydroquinone and related ingredients can also be used in professional artificial nail systems to prevent the liquid component from hardening prematurely in the bottle.
Other ingredients may include “hydroquinone” in their names without acting the same way on the skin. TBHQ, or tert-butylhydroquinone, is primarily used as an antioxidant to help protect a product from degradation. It is not used at concentrations intended to lighten the skin.Hydroquinone, as a skin lightening agent, was once a common ingredient in over-the-counter fade creams and dark-spot treatments (1). Today it requires a prescription in Europe and the United States for this purpose (1,2). Hydroquinone is known to cause ochronosis, which is a blueish greying of the skin that is permanent. Irritation, rashes and facial swelling have also been reported (3). Hydroquinone monomethyl ether is structurally very similar to hydroquinone and lightens skin the same way. In the EU, both hydroquinone and p-hydroxyanisole are prohibited in cosmetics with one narrow exception: professional-use artificial nail systems, at up to 0.02% in the final product, where skin contact is avoided (4). The Cosmetic Ingredient Review, an independent expert panel in the US, has likewise concluded that both are safe only in nail adhesives and as polymerisation inhibitors in nail coatings cured by LED light, and unsafe in leave-on products, citing the potential for skin depigmentation (5,6). Testing has shown that TBHQ can cause mild lightening of skin at 1% and 5%, but not at 0.1%, and on that basis the Cosmetic Ingredient Review concluded it is safe for cosmetic use at concentrations of 0.1% or below (7,8).
Why does Credo prohibit hydroquinone and hydroquinone based compounds?Many compounds in this class have historically been used in skin lightening products. Credo does not market or sell any products used for skin lightening purposes (we do allow products which claim brightening and dark spot treatments). In addition, some ingredients in this category have been associated with permanent skin discoloration and irritation. We have prohibited this chemical class prior to the FDA requiring a prescription for use.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
References
- US FDA. Skin Product Safety. FDA [Internet]. 2026 May 11 [cited 2026 Aug 17]. Available from: https://www.fda.gov/consumers/skin-facts-what-you-need-know-about-skin-lightening-products/skin-product-safety
- European Commission. Commission Regulation (EU) 2021/1099 of 5 July 2021 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products. Official Journal of the European Union [Internet]. 2021 Jul 5. Available from: https://eur-lex.europa.eu/eli/reg/2021/1099/oj/eng
- US FDA. FDA works to protect consumers from potentially harmful OTC skin lightening products [Internet]. Silver Spring, MD: US Food and Drug Administration; 2022 [cited 2026 Aug 17]. Available from: https://www.fda.gov/drugs/drug-safety-communications/fda-works-protect-consumers-potentially-harmful-otc-skin-lightening-products
- European Parliament and Council of the European Union. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products, Annex III entry 95 - Hydroquinone methylether / Mequinol. Official Journal of the European Union [Internet]. 2009 Nov 30. p. 59. Available from: https://eur-lex.europa.eu/eli/reg/2009/1223/oj/eng
- Cosmetic Ingredient Review Expert Panel. Amended Safety Assessment of p-Hydroxyanisole as Used in Cosmetics [Internet]. Washington, DC: Cosmetic Ingredient Review; 2014 Dec [cited 2026 Aug 17]. (Final Amended Report). Available from: https://www.cir-safety.org/sites/default/files/pHydro_122014_FAR.pdf
- Cosmetic Ingredient Review Expert Panel. Amended Safety Assessment of Hydroquinone as Used in Cosmetics [Internet]. Washington, DC: Cosmetic Ingredient Review; 2014 Dec [cited 2026 Aug 17]. (Final Amended Report). Available from: https://www.cir-safety.org/sites/default/files/Hydroq_122014_FAR%20.pdf
- Andersen FA. Annual Review of Cosmetic Ingredient Safety Assessments: 2007-2010. Int J Toxicol. 2011 Oct 1;30(5_suppl). doi:10.1177/1091581811412618
- Cosmetic Ingredient Review Expert Panel. Final Report on the Safety Assessment of t-Butyl Hydroquinone. J Am Coll Toxicol. 1991 Jan;10(1):1–7. doi:10.3109/10915819109078618
Ingredient or Ingredient Class
L-P
-
Methyl Cellosolve
What is Methyl Cellosolve and why is it used in cosmetic and personal care products?Methyl cellosolve, also referred to as 2-Methoxyethanol, had been used as a solvent and as an ingredient to decrease the viscosity of a product. This ingredient is no longer used in cosmetic and personal care products in the U.S.
What does the science say?Methyl cellosolve has been classified by the EU as a presumed reproductive toxicant (1). EU cosmetics law has prohibited use of substances classified as carcinogenic, mutagenic or toxic for reproduction since 2003. This ban rests on hazard alone: it applies regardless of whether expected exposures fall well below the levels that would cause harm. Consequently, this compound is banned in the EU for use in cosmetics (2). In the U.S., although this is not a banned cosmetic ingredient, the U.S. EPA has put into place a rule which minimizes their use in consumer products (3). Specifically, this compound, along with three other solvents (2-methoxyethanol acetate; 2-ethoxyethanol, 2-ethoxyethanol acetate) were largely phased out of consumer products. Since then the EPA put into a rule that any one aiming to manufacture, import or process any of the four ingredients for use in a consumer product must notify the EPA at least 90 days before doing so. This is to give the agency a chance to review the plan and restrict it or stop it from reaching shelves (3). Although this is not an outright ban it does minimize the use of these ingredients in consumer products.
Why does Credo prohibit methyl cellosolve?This compound has been classified as a presumed reproductive toxicant, is banned in the EU from being used in cosmetic products and is highly regulated in the US due to its potential toxicity. As such, Credo prohibits the use of this ingredient in any of its products.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
References
- 2-ethoxyethanol 100.003.459 | Harmonised classifications - ECHA CHEM [Internet]. [cited 2026 Aug 17]. Available from: https://chem.echa.europa.eu/100.003.459/harmonised/202266?searchText=110-80-5
- CosIng - Cosmetics - GROWTH - European Commission [Internet]. [cited 2026 Aug 17]. Available from: https://ec.europa.eu/growth/tools-databases/cosing/details/29061
- U.S. Environmental Protection Agency. 2-Ethoxyethanol, 2-Ethoxyethanol Acetate, 2-Methoxyethanol, and 2-Methoxyethanol Acetate; Significant New Use Rule [Internet]. Vol. 70. Washington, DC: Office of the Federal Register, National Archives and Records Administration; 2005 Nov. p. 71401–6. (Federal Register). Available from: https://www.govinfo.gov/content/pkg/FR-2005-11-29/html/05-23421.htm
-
Methylchloroisothiazolinone & Methylisothiazolinone
What are methylchloroisothiazolinone and methylisothiazolinone and why are they used in cosmetic and personal care products?Methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI) are broad-spectrum preservatives used in cosmetic and personal care products to prevent the growth of bacteria, mold, and yeast. Subsequently they help maintain product safety and shelf life. Although MI may be used alone as a preservative, MCI is only known to be used in combination with MI (1).
What does the science say?MI alone, and in combination with MCI, is a known skin sensitizer (i.e., it can cause allergic contact dermatitis) (1,2). Because of this allergenicity, the EU does not permit these preservatives in leave-on cosmetic products, and permits them in rinse-off products only at very low levels (a maximum of 15 ppm) (3,4). The Cosmetic Ingredient Review panel reviewed both ingredients. For the MCI/MI mixture, the panel concluded it is safe when formulated to be non-sensitizing, and that concentrations should at no point exceed 7.5 ppm in leave-on products or 15 ppm in rinse-off products. For MI alone, the panel concluded it is safe in rinse-off products at up to 100 ppm, and safe in leave-on products when formulated to be non-sensitizing, without an analogous numerical limit (1,5). Methylisothiazolinone was named “Allergen of the Year” in 2013 by the American Contact Dermatitis Society. This was because of the rise in the use of ingredients and the increased incidences of contact allergy being reported (6).
Why does Credo restrict methylchloroisothiazolinone & methylisothiazolinone?
In addition, both MI and MCI/MI have been classified by the European Union under their classification and labeling regulation as very toxic to the aquatic environment based on adverse effects on fish, aquatic invertebrates and algae (7,8). These are hazard classifications: they ask whether a substance could cause harm under some conditions and concentrations, rather than whether it does at the amounts the environment is exposed to.Credo takes a precautionary approach: when credible evidence points to potential harm and viable alternatives exist, we act rather than wait. MI and MCI/MCI are established skin sensitizers, and EU regulators have already restricted them on that basis. The environmental risk is less certain. Both ingredients are classified as very toxic to aquatic life, but how much reaches the environment from cosmetic use and if that creates an environmental risk has not been well characterized. However, where a substance carries that classification and the exposure is uncertain, we treat the hazard as reason enough. Given both, Credo chooses to avoid these ingredients rather than assume low-level exposures are without concern.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
References
- Burnett CL, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, MarksJr. JG, et al. Amended Safety Assessment of Methylchloroisothiazolinone and Methylisothiazolinone as Used in Cosmetics. Int J Toxicol. 2021 Aug 1;40(1_suppl):20S-33S. doi:10.1177/10915818211016382
- Scientific Committee on Consumer Safety. Opinion on Methylisothiazolinone (MI) (P94) Submission III (Sensitisation only). [Internet]. LU: Publications Office; 2015 [cited 2026 Aug 19]. Available from: https://data.europa.eu/doi/10.2875/713830 doi:10.2875/713830
- European Commission. Commission Regulation (EU) 2017/1224 of 6 July 2017 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.). OJ L [Internet]. 2017 Jul 6. Available from: http://data.europa.eu/eli/reg/2017/1224/oj
- CosIng - Cosmetics - GROWTH - European Commission [Internet]. [cited 2026 Aug 19]. Available from: https://ec.europa.eu/growth/tools-databases/cosing/details/35333
- Burnett CL, Bergfeld WF, Belsito DV, Cohen D, Klaassen CD, Liebler DC, et al. Amended Safety Assessment of Methylisothiazolinone as Used in Cosmetics. Int J Toxicol. 2021 Aug 1;40(1_suppl):5S-19S. doi:10.1177/10915818211015795
- Castanedo-Tardana MP, Zug KA. Methylisothiazolinone. Dermat Contact Atopic Occup Drug. 2013;24(1):2–6. doi:10.1097/DER.0b013e31827edc73 PubMed PMID: 23340392.
- ECHA Committee for Risk Assessment. Annex 1 Background document to the Opinion proposing harmonised classification and labelling at EU level of Reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1); Reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) [Internet]. 2016 [cited 2026 Aug 19]. Report CLH-O-0000001412-86-106/F. Available from: https://echa.europa.eu/documents/10162/b5f47054-10ef-83e6-dd87-a7e3eaf1e1f4
- ECHA REACH. Harmonised Classifications [Internet]. 2020 [cited 2026 Aug 19]. 2-methyl-2H-isothiazol-3-one. Available from: https://chem.echa.europa.eu/100.018.399/harmonised/416496?searchText=Methylchloroisothiazolinone
-
Parabens
What are parabens and why are they used in cosmetic and personal care products?Parabens are a family of preservatives that have been used in cosmetic formulations for decades (1,2). Preservatives are used in many cosmetic and personal care products to prevent the growth of bacteria, mold, and yeast, helping to keep products safe and stable (1,2). Common examples of preservatives in the paraben family include: methylparaben, propylparaben, butylparaben, and ethylparaben (1,2). These preservatives all share the same basic building block and differ mainly in the size of a small chemical side chain, or ‘tail.’ This is why they are often sorted into shorter-chain parabens (such as methyl- and ethylparaben) and longer-chain parabens (such as propyl- and butylparaben). This distinction matters as the side chain length is important to their biological activity and thus how their safety is assessed (3,4).
What does science say?Cosmetic safety authorities have studied and repeatedly re-reviewed the safety of parabens in cosmetics for more than 40 years, and their conclusions have shifted as better data has become available (1,2,5,6). Today both the European and U.S. expert bodies conclude that the parabens still permitted in cosmetics are safe for adults at the low levels allowed: in the EU, the shorter-chain methyl- and ethylparaben are permitted at higher concentrations (0.4% for a single paraben, 0.8% for mixtures) while the longer-chain propyl- and butylparaben have been held to a lower 0.14% combined limit since 2014 (7–9). A U.S. expert panel independently reached a similar safe-as-used conclusion for the group (2). Many of the original concerns about paraben safety came from older animal studies that suggested effects on reproduction, but those specific findings were not reproduced in later, higher-quality research (4,7).a In 2025, EU advisors recommended a limit less than the currently approved 0.14% for butylparaben in products for young children, where use across many products can add up (1).
Why does Credo prohibit parabens?
A question that remains open is hormone activity: parabens are “endocrine-active.” Specifically, parabens can mimic estrogen in laboratory tests. This mimicking is weak for the shorter parabens and stronger for longer-chain parabens. However, some reviewers have so far judged the evidence too limited to classify them as true endocrine disruptors in people (3,10). Researchers continue to debate these hormone-related and longer-term questions, including possible links to breast cancer and metabolic effects (11–13).Credo takes a precautionary approach: when credible evidence points to potential long-term health concerns and viable alternatives exist, we act rather than wait for the science to settle. Some parabens have shown endocrine activity in laboratory studies, and questions remain about appropriate concentrations, product types, and cumulative exposure from cosmetics and other sources. Given those uncertainties, Credo chooses to avoid them rather than assume those exposures are without concern.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- Scientific Committee on Consumer Safety. Opinion on butylparaben (CAS No. 94-26-8, EC No. 202-318-7) - Children Exposure - [Internet]. LU: Publications Office of the European Union; 2025 [cited 2026 Jun 22]. Available from: https://data.europa.eu/doi/10.2875/8367360 doi:10.2875/8367360
- Cherian P, Zhu J, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, et al. Amended Safety Assessment of Parabens as Used in Cosmetics. Int J Toxicol. 2020;39(1_suppl):5S-97S. doi:10.1177/1091581820925001
- Nowak K, Ratajczak-Wrona W, Gorska M, Jablonska E. Parabens and their effects on the endocrine system. Mol Cell Endocrinol. 2018 Oct 15;474:238–51. doi:10.1016/j.mce.2018.03.014
- Fransway AF, Fransway PJ, Belsito DV, Yiannias JA. Paraben Toxicology. Dermatitis®. 2019 Feb 1;30(1):32–45. doi:10.1097/DER.0000000000000428
- Cosmetic Ingredient Review. 3 Final Report on the Safety Assessment of Methylparaben, Ethylparaben, Propylparaben, and Butylparaben. J Am Coll Toxicol. 1984;3(5):147–209. doi:10.3109/10915818409021274
- Scientific Committee on Consumer Products. Extended Opinion on the Safety Evaluation of Parabens. 2005. Opinion of the Scientific Committee on Consumer Products on the safety evaluation of parabens.
- Scientific Committee on Consumer Safety. Opinion on Propylparaben (PP). [Internet]. LU: Publications Office; 2021 [cited 2026 Jun 22]. Available from: https://data.europa.eu/doi/10.2875/607198 doi:10.2875/607198
- EU Regulation 1004/2014.
- Scientific Committee on Consumer Safety. Opinion on methylparaben (CAS No. 99-76-3, EC No. 202-785-7). [Internet]. LU: Publications Office; 2024 [cited 2026 Jun 22]. Available from: https://data.europa.eu/doi/10.2875/86920 doi:10.2875/86920
- Matwiejczuk N, Galicka A, Brzóska MM. Review of the safety of application of cosmetic products containing parabens. J Appl Toxicol. 2020;40(1):176–210. doi:10.1002/jat.3917
- Hager E, Chen J, Zhao L. Minireview: Parabens Exposure and Breast Cancer. Int J Environ Res Public Health. 2022 Feb 8;19(3):1873. doi:10.3390/ijerph19031873
- Wei F, Mortimer M, Cheng H, Sang N, Guo LH. Parabens as chemicals of emerging concern in the environment and humans: A review. Sci Total Environ. 2021 Jul 15;778:146150. doi:10.1016/j.scitotenv.2021.146150
- Ramalho A, Vale A, Carvalho F, Fernandes E, Freitas M. Parabens exposure and its impact on diabesity: A review. Toxicology. 2025 Aug 1;515:154125. doi:10.1016/j.tox.2025.154125
-
Phenoxyethanol
What is phenoxyethanol and why is it used in cosmetic and personal care products?Phenoxyethanol is a preservative in cosmetics and personal care products (1). Preservatives are used in many cosmetic and personal care products to prevent the growth of bacteria, mold, and yeast which helps to keep products safe and stable over time. Phenoxyethanol has been used in cosmetic formulations for decades (1).
What does science say?Phenoxyethanol is a well-studied compound, both for its safety and for how it behaves in the human body. It has been studied for more than 40 years, drawing on historical animal toxicologya, modern non-animal methods, and studies in human populations (1–4). The EU Scientific Committee on Consumer Safety (SCCS) most recently reviewed it in 2016, evaluating all of the available safety data (4). The SCCS concluded that phenoxyethanol used at concentrations at or below 1% poses no safety concern for any age group (4).
Why does Credo restrict phenoxyethanol?
This conclusion differs from the position taken by the French health agency (ANSM) which in 2012 recommended that for children under 3, phenoxyethanol should not be used at all in products applied to the diaper area, and should be limited to 0.4% or less in all other products for that age group (5). ANSM’s concern was that, for the youngest children, estimated exposures could exceed the levels considered safe based on the available toxicity studies. When the SCCS reviewed the same data, however, it found that several of ANSM’s exposure assumptions were unrealistic. For example, ANSM assumed a body weight of 3.4 kg (7.5 lbs), roughly the weight of a newborn, for all children from birth to age 3. Because exposure is calculated per kilogram of body weight, using a newborn’s weight for a 3-year-old substantially overstates the dose. ANSM also added together the highest plausible exposure from every infant and toddler product type, as if a single child used all of them at once. Using more realistic assumptions, the SCCS concluded there was no safety concern for children, even at the 1% level (4).
More recently, a small number of human studies have raised questions about a possible link between phenoxyethanol exposure and endocrine (hormone) effects (6,7). These studies found correlations between a breakdown product of phenoxyethanol (i.e., phenoxyacetic acid) and certain hormone-related measures, but several factors make firm conclusions difficult. First, the metabolite measured (phenoxyacetic acid) is not specific to phenoxyethanol. It can arise from other sources, and the study authors themselves noted it may also reflect co-exposure to other ingredients common in cosmetics (6). Either way, a measured association cannot be cleanly attributed to phenoxyethanol. Second, the biological importance of the measured endpoints in these studies is uncertain. Finally, by their nature, observational studies of this kind can reveal associations but cannot show that an exposure caused an outcome. They are best understood as a signal for further investigation, not as evidence of harm. To date, the much larger body of toxicological data on phenoxyethanol does not corroborate the associations these studies suggested. The US EPA also screened phenoxyethanol for estrogen-like activity and found no evidence that it behaves like estrogen (1,8).Given that phenoxyethanol is an effective preservative and preservatives are necessary in most all cosmetics to keep products safe and stable for users. And, given that the available scientific data available indicate phenoxyethanol is safe for all populations if used at 1% or less, Credo has opted to restrict levels of phenoxyethanol to no more than 1% in any products sold in its stores. At this level, its use is supported by the available safety data.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- Dréno B, Zuberbier T, Gelmetti C, Gontijo G, Marinovich M. Safety review of phenoxyethanol when used as a preservative in cosmetics. J Eur Acad Dermatol Venereol JEADV. 2019 Nov;33 Suppl 7:15–24. doi:10.1111/jdv.15944 PubMed PMID: 31588615.
- Api AM, Bartlett A, Belsito D, Botelho D, Bruze M, Bryant-Friedrich A, et al. Update to RIFM fragrance ingredient safety assessment, 2-phenoxyethanol, CAS Registry number 122-99-6. Food Chem Toxicol. 2025 Oct;204:115645. doi:10.1016/j.fct.2025.115645
- Cosmetic Ingredient Review. Final Report on the Safety Assessment of Phenoxyethanol [Internet]. 1990 [cited 2026 Jun 26]. Available from: https://journals.sagepub.com/doi/epdf/10.3109/10915819009078737 doi:10.3109/10915819009078737
- Scientific Committee on Consumer Safety. Opinion on Phenoxyethanol. 2016. Available from: https://health.ec.europa.eu/publications/phenoxyethanol_en
- Agence nationale de securite du medicament et des produits de sante. Evaluation du risque lie a l’utilisation du phenoxyethanol dans les produits cosmetiques. 2012. Available from: https://archive.ansm.sante.fr/var/ansm_site/storage/original/application/8b8904ecdf3e9e56d9ca986a682bbca0.pdf
- Garlantézec R, Warembourg C, Monfort C, Labat L, Pulkkinen J, Bonvallot N, et al. Urinary Glycol Ether Metabolites in Women and Time to Pregnancy: The PELAGIE Cohort. Environ Health Perspect. 2013 Oct 1;121(10):1167–73. doi:10.1289/ehp.1206103 PubMed PMID: 23838187; PubMed Central PMCID: PMC3801453.
- Warembourg C, Binter AC, Giton F, Fiet J, Labat L, Monfort C, et al. Prenatal exposure to glycol ethers and sex steroid hormones at birth. Environ Int. 2018 Apr 1;113:66–73. doi:10.1016/j.envint.2018.01.013
- US EPA O. Endocrine Disruptor Screening Program (EDSP) Estrogen Receptor Bioactivity [Collections and Lists] [Internet]. 2015 [cited 2026 Jun 26]. Available from: https://www.epa.gov/endocrine-disruption/endocrine-disruptor-screening-program-edsp-estrogen-receptor-bioactivity
-
Phthalates
What are phthalates and why are they used in cosmetic and personal care products?Phthalates are chemical compounds that are colorless, odorless and oily. As a group, they are often referred to as plasticizers, as this is their most common use (1). There are many different phthalates which vary in their chemical structure. According to the U.S. FDA the primary ones used in cosmetics are DBP (dibutylphtalate), DMP (dimethylphthalate) and DEP (diethyphthalate). These compounds are used to reduce the brittleness of nail polish (DBP), improve the feel and performance of hair sprays (DMP), and as a solvent in fragrances (DEP) (1). Per FDA’s most recent industry survey (2010), DBP and DMP are used only rarely in U.S. cosmetics, and DEP is the phthalate most commonly still in use, largely in fragrance (1).
What does science say?Phthalates have been reviewed by the scientific community for decades (2–6). The main human health concern with them is related to their potential to cause adverse effects on the male reproductive system mainly through disruption of the endocrine system (3,7,8). The evidence for this concern is strongest for DBP: in animal studies, high doses of DBP given to pregnant rats affected how male reproductive organs developed (3,7,8).a Based on the available data, the EU classified DBP as a substance that may harm fertility or an unborn child (9). Because of this classification DBP is banned from use in cosmetics (10). (Note: These are hazard classifications. They ask whether a substance could cause harm under some conditions, rather than whether it does at the amounts people are actually exposed to). When U.S. safety panels looked specifically at how much DBP people are actually exposed to through cosmetics, they concluded they’re safe at the levels people are exposed to via used cosmetics (2–5).
Why does Credo prohibit phthalates?
DEP and DMP, the other two phthalates, do not have as much evidence when compared to DBP. A major 2018 review of human studies found only weak, inconsistent signals linking DEP to reproductive effects (4). DMP has even less data behind it, and the animal studies that do exist show it’s much less potent than DBP at affecting reproductive development, with no effects seen even at fairly high doses (11).Based on a review of the available data, Credo has opted to take the precautionary approach and prohibit the whole class of phthalates compounds to minimize the potential for any adverse human health effects. These ingredients also reach people through sources beyond cosmetics and each of those uses is reviewed on its own rather than added together. Where credible evidence points to the potential for long-term health concerns (even amid uncertainty) and viable alternatives exist, Credo applies a precautionary approach rather than waiting for the science to settle.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- US FDA. Phthalates in Cosmetics. FDA [Internet]. 2024 Aug 22 [cited 2026 Jul 8]. Available from: https://www.fda.gov/cosmetics/cosmetic-ingredients/phthalates-cosmetics
- Andersen FA. Dibutyl, Dimethyl, and Diethyl Phthalate and Butyl Benzyl Phthalate. Int J Toxicol. 2017 Sep;36(5_suppl2):44S-45S. doi:10.1177/1091581817716148
- Mylchreest E, Cattley RC, Foster PMD. Male Reproductive Tract Malformations in Rats Following Gestational and Lactational Exposure to Di(n-butyl) Phthalate: An Antiandrogenic Mechanism? Toxicol Sci. 1998;43(1):47–60. doi:10.1093/toxsci/43.1.47
- Radke EG, Braun JM, Meeker JD, Cooper GS. Phthalate exposure and male reproductive outcomes: A systematic review of the human epidemiological evidence. Environ Int. 2018 Dec;121:764–93. doi:10.1016/j.envint.2018.07.029
- Scientific Committee on Consumer Products. Opinion on Phthalates in Cosmetic Products [Internet]. 2007 [cited 2026 Jul 8]. Available from: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_106.pdf
- Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. Opinion on diethylphthalate [Internet]. 2002 [cited 2026 Jul 8]. (SCCNFP/0411/01). Available from: https://ec.europa.eu/health/ph_risk/committees/sccp/documents/out168_en.pdf
- ECHA. Phthalates [Internet]. [cited 2026 Jul 8]. Phthalates. Available from: https://www.echa.europa.eu/hot-topics/phthalates
- National Toxicology Program. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di-n-Butyl Phthalate (DBP). 2003 Apr;(4):i-III90. PubMed PMID: 15995736. Available from: https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/phthalates/dbp/dbp_monograph_final.pdf
- ECHA CHEM. Dibutyl phthalate 100.001.416 | Overview - ECHA CHEM [Internet]. 2026 [cited 2026 Jul 8]. Available from: https://chem.echa.europa.eu/100.001.416/overview
- Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast). Official Journal of the European Union [Internet]. 2009 Nov 30. p. 59–209. Available from: https://ec.europa.eu/growth/tools-databases/cosing/reference/annexes/list/II
- Chris Gennings, Hauser R, Koch HM, Kortenkamp A, Lioy PJ, Mirkes PE, et al. Chronic hazard advisory panel on phthalates and phthalate alternatives. 2014. Available from: https://www.cpsc.gov/s3fs-public/CHAP-REPORT-With-Appendices.pdf
Ingredient or Ingredient Class
Q-Z
-
Resorcinol and related ingredients
What is resorcinol (and its related ingredients) and why are they used in cosmetic and personal care products?Resorcinol, also referred to as 1,3 benzenediol or 1,3 dihydroxybenzene, is a synthetic chemical used both on its own and as a starting point for a group of related ingredients (4-chlororesorcinol and resorcinol acetate). These ingredients are used in permanent hair colour (1). Resorcinol reacts with other molecules in a dye formula and imparts a color inside the hair fibers to create permanent dye (1–3). In the EU, resorcinol may also be used in eye lash tints, which must only be applied by professionals. Other related compounds, such as phenylethyl resorcinol and dimethoxytolyl propylresorcinol appear in serums and creams marketed for fading dark spots (4,5).
What does science say?Resorcinol can interfere with thyroid function (3); An observation that has been seen in both historic toxicology studies and in human studies (3,6). The EU’s Scientific Committee on Consumer Safety reviewed the available evidence in 2021 and stated anti-thyroid effects occur with resorcinol but at exposure levels much higher than that anticipated from using hair dyes or eye lash tinting. Ultimately the SCCS concluded “keeping in view the evidence on endocrine disrupting properties of resorcinol, …resorcinol is safe when used as an oxidative hair dye in products intended for hair and eyelashes up to 1.25 % and up to 0.5 % in hair lotions and shampoos” (3). In 2026, the European Chemicals Agency’s Committee for Risk Assessment recommended that resorcinol be classified as a human health endocrine disrupting compound (2). As of August 2026, the EU has not yet decided whether to adopt this opinion. In the United States, the expert panel that reviews cosmetic ingredients last acted on resorcinol in 2008, when it declined to reopen its 1986 assessment, so their position predates most of the modern thyroid evidence (1,7). Resorcinol is also used in the US as an over-the-counter drug ingredient, permitted at low concentrations in acne treatments and certain other topical products (8).
Why does Credo prohibit resorcinol (and related ingredients)?
In its 2010 opinion, the SCCS concluded that resorcinol was a strong sensitiser, meaning relatively low amounts could trigger allergic contact dermatitis (3). However, in its 2021 opinion the SCCS graded it a moderate skin sensitiser on the basis of newly available data, which included clinical studies which report a low frequency of contact sensitisation in people despite widespread use (3).
Resorcinol is also considered very toxic to aquatic life based on the EU Classification and Labeling Regulation (9). This classification describes the substance’s intrinsic hazard rather than the risk from any particular use. A 2006 international review by the WHO/UNEP/ILO International Programme on Chemical Safety found a low probability of harm to surface waters from consumer use of hair dyes, but concluded that a risk to the aquatic environment cannot be excluded at the industrial sites where hair dyes are manufactured (2). The same review found resorcinol readily breaks down in the environment and is unlikely to build up in living organisms (2).
Resorcinol is the starting point for a group of related ingredients. The safety information described above is specific to resorcinol itself, and to its use in hair and eyelash products. They should not be read as findings about all the other ingredients in this family. Those ingredients are chemically related but not identical, they are used in leave-on products applied to the face rather than to hair. Whether these ingredients carry the same concerns as resorcinol has not been established either way.Credo takes a precautionary approach: where credible evidence points to potential health or ecological concerns and viable alternatives exist, we act rather than wait for the science to settle. Resorcinol is permitted in some jurisdictions below set concentrations, but people and the environment may also encounter it from sources beyond cosmetics and each of those uses is assessed separately, not added together. Rather than assume that total exposure is without concern, Credo chooses to avoid resorcinol and related ingredients.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
References
- Cosmetic Ingredient Review. Final Report on the Safety Assessment of 2-Methylresorcinol and Resorcinol. J Am Coll Toxicol. 1986;5(3):167–203. Available from: https://cir-reports.cir-safety.org/view-attachment/?id=46148250-8d74-ec11-8943-0022482f06a6
- Fraunhofer Institute of Toxicology and Experimental Medicine, Inter-Organization Programme for the Sound Management of Chemicals, editors. Concise International Chemical Assessment Document 71 RESORCINOL. Geneva: World Health Organization; 2006. Available from: https://inchem.org/documents/cicads/cicads/cicad71.htm
- Scientific Committee on Consumer Safety. Opinion on resorcinol. [Internet]. LU: Publications Office; 2022 [cited 2026 Aug 20]. Available from: https://data.europa.eu/doi/10.2875/527921 doi:10.2875/527921
- Kim BS, Na YG, Choi JH, Kim I, Lee E, Kim SY, et al. The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers. Nanomaterials. 2017 Aug 28;7(9):241. doi:10.3390/nano7090241 PubMed PMID: 28846658; PubMed Central PMCID: PMC5618352.
- Beaumet M, Lazinski LM, Maresca M, Haudecoeur R. Tyrosinase Inhibition and Antimelanogenic Effects of Resorcinol-Containing Compounds. ChemMedChem. 2024;19(23):e202400314. doi:10.1002/cmdc.202400314
- ECHA Committee for Risk Assessment. Minutes of the 77th Meeting of the Committee for Risk Assessment (RAC-77) Summary Record of the Proceedings, Conclusions and action points [Internet]. 2026 Jun. Report RAC/M/77/2026. Available from: https://echa.europa.eu/documents/d/guest/rac77_final_minutes_en
- Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006 [Internet]. [cited 2026 Aug 20]. Available from: https://cir-reports.cir-safety.org/view-attachment/?id=e4ce160b-8e74-ec11-8943-0022482f06a6
- US FDA. OTC Monograph_M006-Topical Acne drug products for OTC Human Use 11.23.2021 [Internet]. 2021 [cited 2026 Aug 20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M006-Topical%20Acne%20drug%20products%20for%20OTC%20Human%20Use%2011.23.2021.pdf
- ECHA CHEM. | Harmonised classifications [Internet]. [cited 2026 Aug 20]. resorcinol; 1,3-benzenediol. Available from: https://chem.echa.europa.eu/100.003.260/harmonised/225829?searchText=resorcinol
-
Toluene and related ingredients
What is toluene (and related ingredients) and why are they used in cosmetic and personal care products?Toluene functions as an antioxidant and as a solvent (1). Toluene itself is used as a solvent in nail products (2). Other ingredients in this category are chemically derived from toluene. Ingredients derived from toluene are used in a variety of products such as hair dyes and fragrance (3,4). Being derived from toluene does not mean an ingredient shares its properties.
What does science say?Toluene has been evaluated by multiple U.S. and EU government agencies and advisory groups (1,2,5–7). Science has demonstrated that toluene adversely affects the central nervous system, producing headaches, dizziness, and impaired coordination; this is most common in individuals exposed repeatedly or at high levels, such as in an occupational setting (5,7). The U.S. Agency for Toxic Substance and Disease Registry also states that “Day-after-day exposure to low to moderate levels of toluene in the workplace may cause tiredness, confusion, weakness, drunken-type actions, memory loss, nausea, and loss of appetite in some people. These symptoms usually disappear when exposure is stopped” (7). In addition, toluene has been categorized by the EU, under their classification and labeling regulation, as a reproductive toxicant (8). Note: This is a hazard classification. It describes if a substance could cause harm under some conditions, rather than whether it does at the amounts people are actually exposed to.
Why does Credo prohibit toluene (and related ingredients)?
As a volatile organic compound, toluene contributes to the formation of ground-level ozone and fine particulate matter, both of which affect air quality (9,10).Given the known human health toxicity profile of toluene, its potential to impact individuals in an occupational setting and its contribution to decreased air quality, Credo has opted to prohibit toluene, and compounds which are chemically derived from toluene from all products to fulfill the missing of Credo Beauty, to lead by example and meet our standard.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
References
- Cosmetic Ingredient Review. Amended Safety Assessment of Toluene as Used in Cosmetics [Internet]. 2024 Nov [cited 2026 Aug 24]. Available from: https://www.cir-safety.org/sites/default/files/Toluene.pdf
- Scientific Committee on Consumer Products. Opinion of the Scientific Committee on Consumer Products on toluene [Internet]. 2006 Oct [cited 2026 Aug 24]. Report SCCP/1029/06. Available from: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_076.pdf
- Scientific Committee on Consumer Safety. Opinion on Toluene-2,5-diamine and its sulfate: COLIPA n° A5. [Internet]. LU: Publications Office; 2011 [cited 2026 Aug 28]. Available from: https://data.europa.eu/doi/10.2772/31765 doi:10.2772/31765
- The Fragrance Conservatory. The ingredient directory [Internet]. 2026 [cited 2026 Aug 28]. 4’-Methylacetophenone. Available from: https://fragranceconservatory.com/ingredient/4-methylacetophenone
- US EPA. IRIS: Toluene [Reports and Assessments] [Internet]. 2005 [cited 2026 Aug 28]. Toluene. Available from: https://iris.epa.gov/ChemicalLanding/&substance_nmbr%3D118
- Scientific Committee on Consumer Products. Opinion of the Scientific Committee on Consumer Products on toluene (as a solvent in nail cosmetics) [Internet]. 2008 Apr [cited 2026 Aug 24]. Report SCCP/1170/08. Available from: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_133.pdf
- ATSDR. ATSDR Toluene Tox Profile [Internet]. 2017 Jun [cited 2026 Aug 28]. Available from: https://www.atsdr.cdc.gov/ToxProfiles/tp56.pdf
- Toluene 100.003.297 | Overview - ECHA CHEM [Internet]. [cited 2026 Aug 28]. Available from: https://chem.echa.europa.eu/100.003.297/overview?searchText=toluene
- Liu X, Wang M, An T, Zhang X, Wang T, Lara R, et al. Analysis of the abundance and impacts of volatile organic compounds across Europe. Npj Clim Atmos Sci. 2026 Mar 20;9(1):103. doi:10.1038/s41612-026-01378-9
- U.S. EPA. Locating and Estimating Sources of Toluene [Internet]. 1993 [cited 2026 Aug 28]. Available from: https://www.epa.gov/sites/default/files/2020-11/documents/toluene.pdf
-
Triclosan & Triclocarban
What is Triclosan & Triclocarban and why are they used in cosmetic and personal care products?Triclosan and triclocarban are two closely related antibacterial chemicals, often grouped together because they are used in similar ways. In cosmetics they serve two main purposes: (1) as preservatives, keeping a product from growing bacteria, mold or yeast and (2) as a cosmetic biocide, meaning these ingredients can cleanse the skin or prevent odor by inhibiting the growth of or killing off microorganisms (i.e., bacteria, yeast, fungi) (1). They were also widely used in over-the-counter bacterial soaps and body washes and in antiseptic products used in medical facilities (2,3). The OTC and antiseptic uses are also no longer allowed as the FDA concluded there was inadequate data to confirm safety and there was not enough evidence to demonstrate the ingredients worked any better than soap and water (3–5). Triclosan and triclocarban in cosmetics are not prohibited by the FDA, and as such may still be used as preservatives and in deodorants. Though, some states have restricted the use of triclosan (6,7).
What does science say?Both ingredients have been reviewed by the European Union’s Scientific Committee for Consumer Safety (SCCS) (2,8–11). In the U.S. the Cosmetic Ingredient Review panel has reviewed triclosan but has not published any assessment on triclocarban (1).
Why does Credo prohibit Triclosan and Triclocarban?
In 2022 the SCCS evaluated whether either ingredient interferes with hormones. With respect to triclocarban, studies in cells and computer models suggested it can act on estrogen and testosterone signalling, and that it binds weakly to thyroid receptors. Animal studiesa did show hormonal activity; but the SCCS concluded those signals were not tied to a specific adverse health effect, which meant it couldn’t use them to set a safe dose. Studies in people did not provide evidence of hormone disruption. The SCCS concluded that repeated exposure to triclocarban could result in other indications of toxicity, and therefore derived a safe level of exposure based on other effects (e.g., changes in body weight, changes in organ weights) (2). For triclosan, the SCCS stated it “demonstrated estrogenic and an anti-androgenic activity” and there were adverse effects observed in animal studies that could have been caused by these hormone disruptions. The SCCS was able to derive a safe level of exposure below which these effects were not anticipated to occur.
Based on their assessment the SCCS proposed specific concentrations of use for each ingredient by product type. In addition, they stated triclocarban is not considered safe in mouthwash at the maximum permitted level of 0.2%, for adults or children. Triclosan at that same level in mouthwash is considered safe for adults, only if they are not using any other other triclosan-containing products; and is not considered safe for children or teenagers, even used on its own (2).
An additional concern surrounding these ingredients is their potential to increase antimicrobial resistance, due to them washing down the drain after use, the ability to persist in the environment and their known ability to target bacteria (10). The SCCS reviewed this data in 2010 for triclosan specifically. The committee concluded that it could not put a number on the risk of resistance developing from triclosan use, including its use in cosmetics. It also found that triclosan levels measured in some parts of the environment are high enough to suggest resistance could be triggered there; though it was not possible to identify which uses of tricolsan were responsible for the environmental levels. A similar comprehensive evaluation from a cosmetic safety assessment group was not available for triclocarban but the peer reviewed literature indicates the possibility exists due to observations in laboratory and environmental conditions (12–15).Credo takes a precautionary approach: where credible evidence points to potential public health concerns and viable alternatives exist, we act rather than wait for the science to settle. Triclosan and triclocarban have shown hormonal activity in laboratory and animal studies. In addition, both compounds are antimicrobials which wash down the drain and persist in the environment. It was determined by an EU panel that triclosan levels in some parts of the environment are high enough to suggest antibiotic resistance could be triggered; but it wasn’t able to determine which uses are responsible for those levels. We don’t think it’s reasonable to wait for that to be resolved before acting on the products we sell. Given these findings, and in line with what our customers’ preference, Credo doesn’t allow triclosan or triclocarban in our products.
Credo's approachCredo's ingredient restrictions are informed by the Credo Methodology™.
a Credo is committed to advancing cosmetic safety without animal testing and does not accept new animal studies to support ingredient safety. Because animal studies were historically the standard approach used around the world, existing safety information from those studies is part of the scientific record for many ingredients. Rather than repeating animal tests, we use this historical knowledge together with modern, non-animal methods and other scientific evidence to evaluate ingredient safety.
References
- Cosmetic Ingredient Review. Final Report: Triclosan [Internet]. 2010 Dec [cited 2026 Aug 25]. Available from: https://www.cir-safety.org/sites/default/files/FR569.pdf
- Scientific Committee on Consumer Safety. Scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. 2022 Oct. Report SCCS/1643/22. Available from: https://health.ec.europa.eu/publications/safety-triclocarban-and-triclosan-substances-potential-endocrine-disrupting-properties-cosmetic_en
- FDA. Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Docket No. FDA-1975-N-0012; Formerly Part of Docket No. 1975N-0183H [Internet]. 2016 Sep 6. Available from: https://www.federalregister.gov/documents/2016/09/06/2016-21337/safety-and-effectiveness-of-consumer-antiseptics-topical-antimicrobial-drug-products-for
- FDA. 21 CFR 310.545 -- Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. [Internet]. Available from: https://www.ecfr.gov/current/title-21/part-310/section-310.545
- US FDA. Skip the Antibacterial Soap; Use Plain Soap and Water [Internet]. 2026 May 26 [cited 2026 Aug 25]. Available from: https://www.fda.gov/consumers/consumer-updates/skip-antibacterial-soap-use-plain-soap-and-water
- Toxic-Free Cosmetics Act, ch. 70A.560 RCW (triclosan in cosmetic products) [Internet]. Sect. 70A.560. Washington, United States; 2023. Available from: https://app.leg.wa.gov/RCW/default.aspx?cite=70A.560
- Minn. Stat. § 145.945 (triclosan in consumer cleaning products) [Internet]. Sect. 145.945. Minnesota, United States; 2014. Available from: https://www.revisor.mn.gov/statutes/cite/145.945
- Scientific Committee on Consumer Products. Opinion of the Scientific Committee on Consumer Products (SCCP) on triclocarban (P29) for other purposes than as a preservati [Internet]. 2005 Jun [cited 2026 Aug 25]. Report SCCP/0851/04. Available from: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_016.pdf
- Scientific Committee on Consumer Products. Opinion on triclosan COLIPA n° P32 [Internet]. 2009 Jan [cited 2026 Aug 25]. Report SCCP/1192/08. Available from: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf
- Scientific Committee on Consumer Safety. Opinion on triclosan: antimicrobial resistance [Internet]. BE: European Commission; 2010 [cited 2026 Aug 25]. Report SCCP/1251/09. Available from: https://data.europa.eu/doi/10.2772/11162 doi:10.2772/11162
- Scientific Committee on Consumer Safety. Opinion on triclosan: COLIPA n° P27. Addendum to the SCCP Opinion on Triclosan(SCCP/1192/08) from January 2009. [Internet]. LU: Publications Office; 2011 [cited 2026 Aug 25]. Available from: https://data.europa.eu/doi/10.2772/96027 doi:10.2772/96027
- D. Carey, D. Zitomer, K. Hristova, Anthony D. Kappell, P. McNamara. Triclocarban Influences Antibiotic Resistance and Alters Anaerobic Digester Microbial Community Structure. Environ Sci Technol. 2016. doi:10.1021/acs.est.5b03080
- D. Iacopetta, Alessia Catalano, J. Ceramella, C. Saturnino, L. Salvagno, I. Ielo, et al. The Different Facets of Triclocarban: A Review. Molecules. 2021. doi:10.3390/molecules26092811
- Hao Wang, Liying Zhang, Hanlin Cui, Xiaodan Ma, Zhiling Li, Bin Liang, et al. Mechanisms linking triclocarban biotransformation to functional response and antimicrobial resistome evolution in wastewater treatment systems. Water Res. 2024. doi:10.1016/j.watres.2024.121909
- Lu Wang, Tianlun Zhang, Tiangui Cai, Qian Xiang, Xiaohui Liu, Dong Zhu. The pH-specific response of soil resistome to triclocarban and arsenic co-contamination. J Hazard Mater. 2023. doi:10.1016/j.jhazmat.2023.132952
Credo prohibits or restricts certain ingredients and ingredient classes based on considerations related to Human Health (HH), Environmental Health (EH), Ethics & Human Rights (ET), Sustainability (S), and Expert Judgment (EJ). Some ingredient classes are prohibited entirely, while others may be permitted only under specific conditions or uses.
Prohibited: Not permitted under the Credo Standard®.
Restricted: Permitted only under specific conditions or uses (as specified in our Ingredient Standard for Brands and Formulations available for download here)
Why ingredients are listed in the Credo Standard®
Ingredients are added to the Credo Standard® in an effort to fulfill our mission to create a safer, more sustainable, more ethical beauty industry. The below table provides an overview of the key areas that could lead to an ingredient being listed in the Credo Standard®. An ingredient may be listed for one or more of the reasons below.
| Reason for listing | Code | Explanation |
|---|---|---|
| Protect human health | HH | The ingredient has been identified as a potential contributor to adverse health outcomes in people including occupational and community exposures. |
| Protect the health of the environment | EH | The ingredient poses risks to living systems beyond humans, including aquatic organisms, soil ecosystems, wildlife, or other non-human biota. This reflects concern for the health and integrity of natural environments |
| Sustainability concerns | S | The ingredient's sourcing, production, or use contributes to broader planetary concerns such as greenhouse gas emissions, deforestation, or unsustainable resource consumption |
| Ethical considerations | ET | The ingredient's supply chain involves practices that raise concerns about the fair and humane treatment of people or animals. This can include labor practices, animal welfare, and sourcing transparency |
| Other expert judgement | EJ | The ingredient has been flagged by subject matter experts based on available evidence, precautionary considerations, or emerging concerns not yet captured by the other categories. |